Article

Daily Medication Pearl: Ganciclovir Injection

Ganciclovir injection is a nucleoside analogue cytomegalovirus DNA polymerase inhibitor.

Medication Pearl of the Day: Ganciclovir Injection

Indication: Ganciclovir injection is a nucleoside analogue cytomegalovirus (CMV) DNA polymerase inhibitor indicated for the treatment of CMV retinitis in immunocompromised adult patients, including patients with AIDS; prevention of CMV disease in adult transplant recipients at risk for CMV disease.

Insight:

  • Dosing: 5 mg/kg every 12 hours.
  • Dosage forms: Injection 500 mg ganciclovir in 250 mL (2 mg per mL) solution in a single-dose bag for intravenous use.
  • Adverse events: Most common adverse reactions and laboratory abnormalities reported in at least 20% of patients were fever, diarrhea, leukopenia, anemia, catheter related events (including catheter infection and catheter sepsis), and elevated creatinine levels.
  • Mechanism of action: Ganciclovir is an antiviral drug with activity against CMV.

Source: GANCICLOVIR INJECTION Label (fda.gov)

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Tired scared retiree man holding chest with anginal symptoms, pallor and diaphoresis at home. Suffering male with cardiac origin pain, prexcordial pressure, arrhythmia risk, urgent medical attention - Image credit: DimaBerlin | stock.adobe.com
Image credit: Sebastian Kaulitzki | stock.adobe.com
Image credit: Dr_Microbe | stock.adobe.com